Showing results (151-160 of 320) with videos related to
Sort By:
Pageof 32
Journal of Medicinal Chemistry|November 14, 2007
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapyWolfgang F Schmid, Roland O John, Gerhard Mühlgassner, et al.Journal of Medicinal Chemistry|July 18, 2014
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugsHristo P Varbanov, Simone Göschl, Petra Heffeter, et al.Photodiagnosis and Photodynamic Therapy|May 19, 2019
Ex-vivo analysis of quantitative 5-ALA fluorescence intensity in diffusely infiltrating gliomas using a handheld spectroscopic probe: Correlation with histopathology, proliferation and microvascular densityMauricio Martínez-Moreno, Barbara Kiesel, Adelheid Woehrer, et al.Scientific Reports|November 23, 2018
Biological activity of Pt<sup>IV</sup> prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysisSilvia Alonso-de Castro, Alessio Terenzi, Sonja Hager, et al.Molecular Cancer Therapeutics|June 18, 2009
Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cellsFlorence Lefranc, Sébastien Sauvage, Gwendoline Van Goietsenoven, et al.Oncotarget|October 31, 2015
Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagyNastasia Wilfinger, Shane Austin, Barbara Scheiber-Mojdehkar, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 12, 2010
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339Petra Heffeter, Katharina Böck, Bihter Atil, et al.Journal of Medicinal Chemistry|June 24, 2016
Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance CircumventionChristian R Kowol, Walter Miklos, Sarah Pfaff, et al.Cancers|July 27, 2024
Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [<sup>18</sup>F]FDG-PET/MRILena Zachhuber, Thomas Filip, Behrang Mozayani, et al.Neoplasia (New York, N.Y.)|May 5, 2009
Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expressionMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.Pageof 32